Mr Erik Walldén (1949) has a record of achievement from over 30 years leadership in the international Life Science industry. He led the global launching of several new technologies, established and restructured companies, and successfully closed private placements and IPOs. He is currently acting as consultant and advisor through his own company Erik Wallden AB.
Erik was the CEO for the Swedish company Gyros AB (2009–2013). Before that he was the CEO of the Swedish biotech company Affibody Holding AB (2006–2009), Biacore International AB (2004–2006), and the CEO of Pyrosequencing AB (1998–2004). Erik has been active in establishing and taking part in the executive management of companies such as the US-based PerSeptive Biosystems Inc., Pharmacia Biosensor AB and Pharmacia Biotech AB. He is the Chairman of the Board of Erik Wallden AB, and Director of Virgin Instruments Inc. and CellSeed AB.
Sign up for the Beactica newsletter to receive our latest news and updates